tbuckley/cabot-search huggingface dataset:
Bendamustine Plus Brentuximab Has Superior Efficacy to Brentuximab Monotherapy As Third-Line Treatment for Classical Hodgkin Lymphoma: A Real-World, Multicentre UK Analysis
Authors: Rohan Shotton, Amy A Kirkwood, Michael Northend, Dina Fathoala, Kieran Burton, Graeme Ferguson, Laura Aiken, Caroline Shrubsole, Lauren Henry, Mary Owen, Rebecca Oliver, Nicolas Martinez-Calle, Astrid Etherington, Eve Gallop-Evans, Cathy Burton, Fiona Miall, Wendy Osborne, Rifca Le Dieu, Pamela McKay, Satyen H Gohil, Graham P. Collins, Elizabeth H Phillips
Journal: Blood (2023)
KPT-8602 Induced Hematopoietic Differentiation in <i>U2AF1 S34F</i> Mutant Cells and Myelodysplastic Syndromes Bone Marrow Stem and Progenitor Cells
Authors: Valeria Velez Galiano, Gloria Garcia, David M Swoboda, Katherine McKinnon, Dan Larson, Kathy L McGraw
Journal: Blood (2023)
Real-World Overall Response Rate (ORR) of Diffuse Large B-Cell Lymphoma with Polatuzumab Vedotin-Based Theraphy, a Multicentric Study in Mexico
Authors: SilviaMargarita RodriguezMejorada, Alberto Villalobos Prieto, Adrían Alejandro Ceballos López, Eduardo Edmundo Reynoso Gomez, Celia Carela Sandoval Villa, Francisco Jose Tripp Villanueva, Diego Cruz Contreras, Alicia Elizabeth Guzman Hernandez, Omar Genaro Lopez Navarro, Yvette Neme Yunes, Oscar De Jesus Perez Ramirez, Enrique Rico Curiel, Diego Mauricio Barbosa Loria
Journal: Blood (2023)
A Multicenter Clinical Study with Reduced Intensive Chemotherapy for Induction Remission of Pediatric Acute Megakaryoblastic Leukemia
Authors: Yixin Hu, Minghua Yang, Ningling Wang, Linhai Yang, Xiaowen Zhai, Hongsheng Wang, Chun Li, Yufeng Liu, Xueju Xu, Qi An, Jixia Luo, Liangchun Yang, Xiaojun Yuan, Qianfei Wang, Ning Liao, Hua Jiang, Xiuli Ju, Xiaoming Wang, Yi Wang, Peifang Xiao, Jun Lu, Hailong He, Raul C. Ribeiro, Shaoyan Hu
Journal: Blood (2023)
Pet-2 Positive during Frontline Therapy: An Early Unfavorable Predictor for Subsequent Salvage High-Dose Chemotherapy (HD-CT) and Autologous Stem Cell Transplant in Relapsed or Refractory Classical Hodgkin Lymphoma
Authors: Simonetta Viviani, Anna Vanazzi, Samuele Frassoni, Chiara Rusconi, Andrea Rossi, Alessandra Romano, Caterina Patti, Corrado Schiavotto, Roberto Sorasio, Vincenzo Marasco, Laura Lissandrini, Davide Rapezzi, Daniela Gottardi, Federica Cocito, Antonio Mulé, Salvatore Leotta, Guido Gini, Marco Sorio, Enrico Derenzini, Alessandro Rambaldi, Corrado Tarella, Vincenzo Bagnardi
Journal: Blood (2023)
Long Term Durable Responses in Relapsed/Refractory (r/r) ALL, DLBCL, and FL Patients Treated with Tisagenlecleucel and Its Association with Persistence of CAR T-Cells
Authors: Rakesh Awasthi, Edward Waldron, Stephan Grupp, Michael A. Pulsipher, Peter Bader, Stephen J Schuster, Richard T Maziarz, Edmund K. Waller, Ulrich Jaeger, Catherine Thieblemont, Martin Dreyling, Nathan Fowler, Harald Jakob Maier, Jennifer Willert
Journal: Blood (2023)
Non-Canonical Double Mutant <i>DNMT3A</i> mutations: Clinical and Biological Significance in Myeloid Neoplasms
Authors: Sushmitha Nanja Reddy, Jeff Aguilar, Lakshmi Bhavani Potluri, Vikram Dhillon, Dakshin Padmanabhan, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian, Julie Boerner, Gregory Dyson
Journal: Blood (2023)
Addition of Chidamide to a Sandwich Protocol, Pegaspargase, Gemcitabine and Oxaliplatin Chemotherapy Combined with Radiotherapy, As First-Line Treatment in Early Stage NK/T-Cell Lymphoma: Real World Outcomes in a Retrospective Study
Authors: Fan Xia, Nana Ping, Qi Bao, Rui Zou, Qian Zhu, Xiao Zhang, Depei Wu, Zhengming Jin, Changju Qu
Journal: Blood (2023)
Impact of Anti-Thymocyte Globulin on Procalcitonin Levels Comparison during Fever in Allogeneic Stem Cell Transplantation Conditioning
Authors: Takahiro Shima, Mariko Minami, Yasuo Mori, Shin-ichi Mizuno, Toshihiro Miyamoto, Koji Kato, Koichi Akashi
Journal: Blood (2023)
Five-Year Follow up Results of Phase II Clinical Trial Evaluating Ruxolitinib (RUX) and Azacitidine (AZA) Combination Therapy in Patients (pts) with Myelodysplastic Syndrome/Myeloproliferative Neoplasms (MDS/MPNs)
Authors: Sankalp Arora, Jayastu Senapati, Naveen Pemmaraju, Prithviraj Bose, Lucia Masarova, Guillermo Montalban-Bravo, Abhishek Maiti, Tapan M. Kadia, Elias Jabbour, Guillermo Garcia-Manero, Hagop M. Kantarjian, Naval Daver
Journal: Blood (2023)
Antagonizing Vasoactive Intestinal Peptide (VIP) Receptors on CAR T Cells Improves Efficacy and Persistence
Authors: Heather Lin, Dejah Blake, Abhijay Mudigonda, Alysa N Evans, Ruby Freeman, Tanisha Sinha, Fan Fei, Elyse Christensen, Tenzin Passang Fnu, Sruthi Ravindranathan, Tongrui Liu, Lily Yang, Edmund K. Waller, Sarwish Rafiq
Journal: Blood (2023)
Epitope Edited Hematopoietic Stem Cells to Enable Synergistic Immunotherapy Combinations for Acute Myeloid Leukemia
Authors: Gabriele Casirati, Andrea Cosentino, Adele Mucci, Mohammed S Mahmoud, Iratxe Ugarte Zabala, Jing Zeng, Scott Ficarro, Denise Klatt, Christian Brendel, Alessandro Rambaldi, Jerome Ritz, Jarrod Marto, Danilo Pellin, Daniel E. Bauer, Scott A Armstrong, Pietro Genovese
Journal: Blood (2023)
Combined Single Cell Flow Cytometry and Imaging Analyses Reveal Immunomodulatory Effects Exerted By Targeted Phospho-SYK Inhibitors with Elevated Sensitivity in NPM1 Mutated AML
Authors: Bridget A Robinson, Philipp Sergeev, Yoko Kosaka, Thomas Jacob, Andy Kaempf, Evan F. Lind, Cristina Tognon, Luis A. Carvajal, Jorge F. DiMartino, Caroline A. Heckman, Tania Q Vu
Journal: Blood (2023)
An Indirect Comparison of Elranatamab's Progression-Free Survival and Overall Survival from Magnetismm-3 Versus Real-World External Control Arms in Triple-Class Refractory Multiple Myeloma
Authors: Luciano Costa, Thomas W LeBlanc, Hans Tesch, Pieter Sonneveld, Ryan Kyle, Liliya Sinyavskaya, Patrick Hlavacek, Aster Meche, Jinma Ren, Alex Schepart, Didem Aydin, Guido Nador, Marco DiBonaventura
Journal: Blood (2023)
Modification of the ELN Classification 2022 Refines Risk Assessment in MDS/AML Patients
Authors: Sandra Huber, Constance Regina Baer, Stephan Hutter, Frank Dicker, Irene Fuhrmann, Manja Meggendorfer, Christian Pohlkamp, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach, Gregor Hoermann
Journal: Blood (2023)
Results of a Phase II Study of Cladribine, Low Dose Cytarabine and Venetoclax, Alternating with Azacitidine and Venetoclax in Patients with Higher Risk Chronic Myelomonocytic Leukemia or Myelodysplastic Syndromes
Authors: Guillermo Montalban-Bravo, Nicholas J. Short, Kelly S. Chien, Yesid Alvarado Valero, Naval Daver, Gautam Borthakur, Mahesh Swaminathan, Abhishek Maiti, Danielle E. Hammond, Graciela Nogueras-Gonzalez, Xuelin Huang, Heather Schneider, Kristen Shelly, Tapan M. Kadia, Hagop M. Kantarjian, Guillermo Garcia-Manero
Journal: Blood (2023)
Survival Outcomes, Efficacy and Tolerability of a Pediatric-Inspired Regimen (MASPORE) for Philadelphia-Negative Acute Lymphoblastic Leukemia in Young Adults at a Tertiary Hospital in Singapore
Authors: Victor Ling Wei Teik, Sai Lon Wann, Jing Yuan Tan, Jameelah Sheik Mohamed, Wei Ying Jen, Pak Ling Lui, Michelle Poon, Esther Hian Li Chan, Liang Piu Koh, Lip Kun Tan, Chin Hin Ng, Allen Eng Juh Yeoh, Melissa Ooi
Journal: Blood (2023)
Efficacy and Safety of AALL0232 Protocol in Adults with Acute Lymphoblastic Leukemia: Single Institution Experience
Authors: Abdullah M. Alrajhi, Mashael Alrouqi, Jude Howaidi, Mohammmad Alwadi, Hassan Alshehri, Imran K Tailor, Mohammed S Alnoamani, Nawal F Alshehry, Ibraheem H Motabi, Mohammed A Marei, Muhned Alhumaid
Journal: Blood (2023)
Retrospective Analysis of Clinical Outcomes of Utilizing R-CHOP Plus Zanubrutinib for High-Risk Diffuse Large B Cell Lymphoma Patients with Extranodal Involvement or MYC/BCL2 Double Expression
Authors: Wanbin Fu, Jia Liu, Dan Xiao, Huanbin Zhao, Ting Wang, Jiong Hu, Jian Hou, Hua Zhong, Lan Xu
Journal: Blood (2023)
Treatment Outcomes for Adults with Mixed Phenotypic Acute Leukemia: A Large Single-Center Retrospective Study
Authors: Jennifer J. Huang, Jacob S. Appelbaum, Kathryn Russell, Carole Shaw, Ashley M. Eckel, Xueyan Chen, Rutu D. Vyas, Paul C. Hendrie, Anna B. Halpern, Raya Mawad, Ryan D Cassaday, Roland B. Walter, Mary-Elizabeth M. Percival, Cristina Maria Ghiuzeli
Journal: Blood (2023)
Humanized Monoclonal Antibody IMM47, Targeting CD24, Exhibits Exceptional Anti-Tumor Efficacy By Blocking the CD24/Siglec-10 Interaction and Can be Used As Monotherapy or in Combination with Anti-PD1 Antibodies for Cancer Immunotherapy
Authors: Jifeng Yu, Song Li, Dianze Chen, Huiqin Guo, Yanan Yang, Dandan Liu, Chunmei Yang, Xing Bai, Wei Zhang, Li Zhang, Gui Zhao, Xiaoping Tu, Liang Peng, Sijin Liu, Yongping Song, Zhongxing Jiang, Ruliang Zhang, Wenzhi Tian
Journal: Blood (2023)
Co-Occurrence of Familial Mediterranean Fever and Hematologic Malignancies: Case Report Series
Authors: Lusine Harutyunyan, Anahit Ter-Grigoryan, Marine Melik-Andreasyan, Gevorg Saghumyan, Lala Vagharshakyan, Dickran Kazandjian, Hasmik Oseyan, Armine Farmazyan, Maria Badikyan, Nare Martirosyan, Artem Oganesyan, Arusyak Ivanyan, Karen Meliksetyan, Diana Soghomonyan, Tatevik Khachatryan, Elen Avanesyan, Hasmik Tumanyan, Samvel Danelyan, Astghik Voskanyan, Gevorg Tamamyan
Journal: Blood (2023)
Trial in Progress: Patient-Reported Outcome Measures in the Prospective Observational Cohort Study of Patients at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)
Authors: Doris M. Ponce, Areej El-Jawahri, Betty K. Hamilton, Nandita Khera, Valkal Bhatt, John Galvin, Catherine J. Lee
Journal: Blood (2023)
A Novel Model Combining Circulating Absolute Monocyte Counts and a Four-Gene Monocyte Signature in Leukapheresis Identifies Lymphoma Patients at Very High Risk of Progression after Tisagenlecleucel or Axicabtagene Ciloleucel Therapy
Authors: Cristiana Carniti, Martina Magni, Nicole Caldarelli, Tommaso Torelli, Luca Agnelli, Eugenio Fardella, Daniele Lorenzini, Arianna Rigamonti, Sadhana Jonnalagadda, Giada Zanirato, Anisa Bermema, Silvia Brich, Anna Dodero, Annalisa Chiappella, Paolo Corradini
Journal: Blood (2023)
Prevention of CMV/EBV Reactivation By Double-Specific T Cells in Patients after Allogeneic Stem Cell Transplantation: Results from the Randomized Phase I/IIa Multivir-01 Study
Authors: Armin Gerbitz, Regina Gary, Michael Aigner, Andreas Moosmann, Anita Kremer, Christoph Schmidt, Klaus Hirschbuehl, Eva Wagner Drouet, Beate Hauptrock, Daniel Teschner, Wolf Roesler, Bernd Spriewald, Johanna Tischer, Stephanie Moi, Heidi Balzer, Stefanie Schaffer, Judith Bausenwein, Anja Wagner, Franziska Schmidt, Jens Brestrich, Barbara Ullrich, Stefanie Maas, Susanne Herold, Julian Strobel, Robert Zimmermann, Volker Weisbach, Leo Hansmann, María Fernanda Lammoglia Cobo, Mats Remberger, Matthias Stelljes, Francis A. Ayuk, Robert Zeiser, Andreas Mackensen
Journal: Blood (2023)
Nex-T TM Cluster of Differentiation 19 (CD19) Chimeric Antigen Receptor (CAR) T-Cell Therapy BMS-986353 (CC-97540): Comparative Analysis of Baseline Patient Data from Trials in Systemic Lupus Erythematosus (SLE) and Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL) Related to Manufacturability and Potential Safety
Authors: Fabian Mueller, Julie Rytlewski, Chun Wu, Sarah Hu, Ashley Koegel, Nikolay Delev, Ana Kostic, Vaishali Shah, Thomas Wegman, Georg Schett
Journal: Blood (2023)
Ixazomib, Pomalidomide and Dexamethasone (IxPd) in Relapsed or Refractory Multiple Myeloma (RRMM) Characterized with High-Risk Cytogenetics. IFM 2014-01
Authors: Arthur Bobin, Salomon Manier, Joe De Keizer, Cyrille Hulin, Lionel Karlin, Denis Caillot, Clara Mariette, Carla Araujo, Bertrand Arnulf, Benoit Bareau, Karim Belhadj Merzoug, Lotfi Benboubker, Thorsten Braun, Claire Calmettes, Olivier Decaux, Mamoun Dib, Helene Demarquette, Pierre Feugier, Cécile Sonntag, Arnaud Jaccard, Pascal Lenain, Margaret Macro, Valentine Richez, Mourad Tiab, Laure Vincent, Hacene Zerazhi, Marie-Odile Petillon, Cyrille Touzeau, Aurore Perrot, Philippe Moreau, Thierry Facon, Herve Avet Loiseau, Xavier Leleu
Journal: Blood (2023)
Cytokine and Mutation Profiling Reveal Patterns of Complete Remission Rates with Lenzilumab Combination Therapy in Chronic Myelomonocytic Leukemia
Authors: Monika Kutyna, Maha M Kamel, David M. Ross, Agnes S. M. Yong, Chun Yew Fong, Chloe Thompson-Peach, Steven W. Lane, David T Yeung, Timothy P Hughes, Devendra Hiwase, Daniel Thomas
Journal: Blood (2023)
British Columbia Experience in Allogeneic Stem Cell Transplantation for Myelofibrosis with or without Pre-Transplant Ruxolitinib
Authors: Shanee Chung, Ashley Kate McEwan, Yasser Abou Mourad, Donna L. Forrest, Kevin Hay, Florian Kuchenbauer, Stephen H. Nantel, Thomas J. Nevill, Judith Anula Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J Stubbins, Cynthia L. Toze, Jennifer White, Sujaatha Narayanan
Journal: Blood (2023)
Functional Diversification and Dynamics of CAR-T Cells in B-ALL Patients
Authors: Zongcheng Li, Lei Zhao, Yuanyuan Zhang, Li Zhu, Wei Mu, Tong Ge, Jin Jin, Jiaqi Tan, Jiali Cheng, Jue Wang, Na Wang, Xiaoxi Zhou, Liting Chen, Zhilin Chang, Chen Liu, Bian Zhilei, Bing Liu, Lilin Ye, Yu Lan, Liang Huang, Jianfeng Zhou
Journal: Blood (2023)
Impact of the Mexican Healthcare Reform on Optimal Treatment Delivery, Survival, and Response Rates Among a Cohort of Patients with Diffuse Large B Cell Lymphoma in a Single National Reference Institution
Authors: Francisco Javier Gutiérrez Ramírez, Alejandro Aviles, Francisco Osvaldo García-Pérez, Valentin Lozano, Myrna Candelaria
Journal: Blood (2023)
PPARG and ASS1: Targets of Metabolic Alteration in Venetoclax / Decitabine Resistant Acute Myeloid Leukemia
Authors: Kotoko Yamatani, Tatsuro Watanabe, Kaori Saito, Abhishek Maiti, Satoshi Yamashita, Abdullah Khasawneh, Faith Jessica Paran, Kala Hayes, Gautam Borthakur, Joe R Harman, Shinya Kimura, Courtney D. DiNardo, Thomas A Milne, Michael Andreeff, Yoko Tabe, Marina Y. Konopleva
Journal: Blood (2023)
A Phase I Study of Ruxolitinib in Combination with Abemaciclib for Patients with Primary or Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
Authors: Jan Philipp Bewersdorf, Andriy Derkach, Lucia Masarova, Naveen Pemmaraju, Eytan M. Stein, Michael Mauro, Raajit K. Rampal, Prithviraj Bose
Journal: Blood (2023)
Health Related Quality of Life in Patients with Primary ITP Compared with Population Norms: A Multicenter Retrospective Analysis of Data from Norwegian ITP Registry
Authors: Riccardo Tomasello, Lamya Garabet, Heidi Pettersen, Hoa Tran, Mazdac Tavoly, Galina Tsykunova, Eirik Tjønnfjord, Mariasanta Napolitano, Waleed Ghanima
Journal: Blood (2023)
GDF11/SMAD Regulated Splicing of <i>GATA1</i> Is Associated with Response to Luspatercept in Lower-Risk Myelodysplastic Syndromes (LR-MDS)
Authors: Srinivas Aluri, Ellen Fraint, Samarpana Chakraborty, Aarif Ahsan, Gowri Poigailwar, Rongbao Zhao, Kith Pradhan, Kimo Bachiashvili, Anjali Budhathoki, Beamon Agarwal, Shanisha Gordon Mitchell, Milagros Carbajal, Srabani Sahu, Jacqueline Boultwood, Andrea Pellagatti, Ulrich Steidl, Amittha Wickrema, Satish Nandakumar, Aditi Shastri, Teresa Bowman, Sadanand Vodala, Amit K. Verma
Journal: Blood (2023)
<i>Evaluating the Impact of Hereditary Thrombotic Thrombocytopenic Purpura (hTTP) on Patients: A Patient Reported Outcomes (PROs) Study</i>
Authors: Azra Borogovac, Honieh Sowdagar, Julia Naifeh, Marissa Schraner, Johanna A. Kremer Hovinga, Devon Mack, Sara Vesely, James N. George, Deirdra Terrell
Journal: Blood (2023)
A Matching-Adjusted Indirect Comparison of the Efficacy of Elranatamab Versus Physician's Choice of Treatment Among Patients with Triple-Class Exposed/Refractory Multiple Myeloma in Canada
Authors: Isha Mol, Yannan Hu, Fiorella Fanton-Aita, Phu Vinh On, Hicham Gonzalez, Richard LeBlanc, Donna Reece, Jiandong Su, Engin Gul, Alissa Visram, Joseph C Cappelleri, Haitao Chu, Guido Nador, Patrick Hlavacek
Journal: Blood (2023)
Thrombosis and Bleeding Outcomes Among Veterans with Chronic Myeloid Leukemia and Association with Agent Orange Exposure
Authors: Matthew Rosenthal, Zoe McKinnell, Andrew Tiu, Daniel Tuerff, Puneet Gill, Martha Antonio, Shanshan Liu, Guoqing Diao, Ramesh Subrahmanyam, Craig Kessler, Maneesh Rajiv Jain
Journal: Blood (2023)
Interaction between JAK2-Mutated Neutrophils and Platelets Initiates Thrombosis Via Neutrophil Extracellular Traps
Authors: Koki Ueda, Saori Miura, Tomofumi Misaka, Keiji Minakawa, Yuka Sato, Yasuchika Takeishi, Kazuhiko Ikeda
Journal: Blood (2023)
The Characterization of Metabolic Profile and Substrates Dependencies of Richter's Syndrome Cells Open for Translational Opportunities
Authors: Matilde Micillo, Lorenzo Brandimarte, Giulia Omezzolli, Nadia Bertola, Francesco Edoardo Vallone, Andrea Iannello, Chiara Lavarello, Nicole Grinovero, Giulio Ferrero, Kevin Mellert, Peter Moller, Nicoletta Vitale, Silvia Bruno, Richard R. Furman, John N. Allan, Andrea Petretto, Silvia Deaglio, Silvia Ravera, Tiziana Vaisitti
Journal: Blood (2023)
AML with t(4;12)(q12;p13): A Detailed Genomic and Transcriptomic Analysis Reveals Genomic Breakpoint Heterogeneity, Absence of <i>Pdgfra</i> Fusion Transcripts and Presence of <i>Pdgfra</i> Overexpression in a Subset of Cases
Authors: Angelika Müller-Jochim, Manja Meggendorfer, Wencke Walter, Torsten Haferlach, Wolfgang Kern, Claudia Haferlach
Journal: Blood (2023)
A Conditioning Regimen of Bendamustine and Melphalan for Autologous Stem Cell Transplantation in Multiple Myeloma: A Phase 2, Single-Arm, Prospective Study
Authors: Qiang Zeng, Jian Li, Tian Dong, Xinchuan Chen, Pu Kuang, Ting Niu, Jie Ji, Zhigang Liu, Ting Liu
Journal: Blood (2023)
Adaptor Anti-P329G CAR T Cells for Modular Targeting of AML
Authors: Sophia Stock, Thaddaeus Strzalkowski, Adrian Gottschlich, Lisa Rohrbacher, Luisa Fertig, Vivien D. Menkhoff, Marlena Surowka, Peter Bruenker, Diana Darowski, Stefan Endres, Michael von Bergwelt-Baildon, Marion Subklewe, Christian Klein, Sebastian Kobold
Journal: Blood (2023)
Engraftment Syndrome Incidence after Immune Checkpoint Inhibitor Therapy in Pts with Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation: A Single Institutional Review
Authors: Oluwatobi Odetola, Kehinde Adekola, Jonathan Moreira, Reem Karmali, Shuo Ma, Kenneth R. Carson, Jayesh Mehta, Jane N. Winter, Leo I. Gordon, Adam Yuh Lin
Journal: Blood (2023)
Inter-Facility Evaluation of Machine Learning Based Deep Hematopoietic Cell Classifiers for Cytological Evaluation of Hematopoiesis
Authors: Julian Thull, Martina Crysandt, Barbara Klinkhammer, Peter Boor, Tim H. Brümmendorf, Volkmar Schulz, Barbara Klinkhammer, Dorit Merhof, Edgar Jost
Journal: Blood (2023)
Preliminary Safety Results of the Open-Label Phase of a 2-Part Phase 1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of an Investigational Microbiome Therapeutic, SER-155, in Adults Undergoing Hematopoietic Cell Transplantation
Authors: Doris M. Ponce, Satyajit Kosuri, Nandita Khera, Zachariah Defilipp, David I Lichter, Jonathan U Peled, Marcel R.M. van den Brink, Kelly Brady, Matthew D Puhl, Gabrielle Glick, Brooke Hasson, Barbara H McGovern, Lisa von Moltke, Bina Tejura
Journal: Blood (2023)
Pharmacokinetics, Drug Interaction, and Exposure-Safety Analyses of Tazemetostat When Co-Administered with Lenalidomide and Rituximab in Patients with Relapsed/Refractory Follicular Lymphoma: Phase 1b Results of Symphony-1
Authors: Yingxue Chen, Rajat Bannerji, Renli Teng, Attila Szanto, Julien Ogier
Journal: Blood (2023)
Deciphering the Epigenetic Landscape in Histiocytic Neoplasms
Authors: Mali Salmon-Divon, Refael Meyuchas, Jamal Benhamida, Ofer Shpilberg, Roei D. Mazor, Mariko Yabe, Kseniya Petrova-drus, Omar Abdel-Wahab, Eli L. Diamond, Oshrat Hershkovitz-Rokah
Journal: Blood (2023)
Emicizumab Efficacy in Severe Hemophilia (A): Experience in Ecuador
Authors: Héctor Chiang Wong, Jessyca Manner Marcillo, Katiuska Moreno Peñarrieta, Claudia Ochoa, Verónica Ullauri Zambrano, Libet Bosch González, Katheryn Garzón Velásquez, Liermis Michael Dita Salabert, Roberto Garibaldi
Journal: Blood (2023)
Real World Outcomes of CPX-351 Compared to Traditional Chemotherapy with Cytarabine Consolidation for Treatment of Secondary Acute Myeloid Leukemia
Authors: Katelynn Granger, Kelly J Gaffney, Deidra Smith, Erin Weeda, Praneeth Baratam, Kimberly Michelle Green, Alexander Coltoff, James A Davis
Journal: Blood (2023)
Reinfusion of Varnimcabtagene Autoleucel (IMN-003A) in Patients with Relapsed Refractory B Cell Malignancies Is Feasible with Sustained Responses
Authors: Sharat Damodar, Raja Thirumalairaj, Akshatha Nayak, Shilpa Prabhu, Rameez Ahamed, Deepak MB, Sudarshan Chougule, Lakshman Vaidhyanathan, Karthik GA, Sunil HV, Shelley Simon, Jayaraj Govindaraj, Pallavi Arasu, Sri Ramulu Elluru, Mohammed Manzoor Akheel, Anil Kamat
Journal: Blood (2023)
Role and Prevalence of Risk Factors That Trigger Therapy Related Myeloid Neoplasms (TRMN) in Patients with Previous Treated Breast Cancer
Authors: Oriol Calvete, Rashmi Kanagal-Shamanna, Julia Mestre, Guillermo Montalban-Bravo, Courtney D. DiNardo, Koji Sasaki, Jessica Aranda, Pamela Acha, Blanca Xicoy, Ana Pérez González, Laura Palomo, Maria Julia Montoro, Mireia Margeli, Francesc Sole
Journal: Blood (2023)
Neighborhood Socioeconomic Disadvantage and Distance from Treatment Center Do Not Impact Survival Outcomes of Patients with Non-Hodgkin Lymphoma and Multiple Myeloma Treated with CAR T-Cell Therapies
Authors: Agrima Mian, Danai Dima, Betty K. Hamilton, Allison Winter, Jack Khouri, Louis S. Williams, Shahzad Raza, Deepa Jagadeesh, Aaron T. Gerds, Robert M. Dean, Matt Kalaycio, Claudio Brunstein, Craig S Sauter, Faiz Anwer, Brian T. Hill, Paolo Caimi
Journal: Blood (2023)
Single-Cell RNA-Seq Reveals Intermediate Cell States and Identifies Features Defining Cellular Heterogeneity in Inv(16) Acute Myeloid Leukemia (AML)
Authors: Yu-Hsuan Fu, Lianjun Zhang, Ying-Chieh Chen, David Frankhouser, Lisa Uechi, Denis O'Meally, Sergio Branciamore, Guido Marcucci, Russell C. Rockne, Ya-Huei Kuo
Journal: Blood (2023)
The Prognostic Significance of 1-Year Persistent MRD Negativity in Chinese ALL Patients: 5-Year Follow-up Results from RJ-ALL 2014 Trial
Authors: Jiayi Ren, Sijie Tang, Weiyang Liu, Xiangqin Weng, Cheng Wang, Lijun Peng, Wenqian Xu, Yuxuan Shang, Jie Hao, Wenyan Yu, Jiaojiao Zhang, Jie Xu, Yuanfang Liu, Weiping Zhang, Jin Wang, Jian-Qing Mi
Journal: Blood (2023)
Investigation of Clonal Hematopoiesis in New Japanese Cohort
Authors: Kenichi Makishima, Kashima Yukie, Yuta Kuze, Sakurako Suma, Yoshiaki Abe, Yasuhito Suehara, Tatsuhiro Sakamoto, Keiichiro Hattori, Sakura Kito, Tran Bich Nguyen, Manabu Fujisawa, Shigeru Chiba, Mamiko Sakata-Yanagimoto, Yutaka Suzuki
Journal: Blood (2023)
TAF1, the Largest Subunit of Tfiid, Is Dispensable for Adult Hematopoiesis
Authors: Fan Liu, Jingyin Yue, Francesco Tamiro, Jun Sun, Pradeepkumar Reddy Cingaram, Krystal Lisa Hossack, Concepcion Martinza Caja, Felipe Beckedorff, Ramin Shiekhattar, Stephen D. Nimer
Journal: Blood (2023)
Frontline Venetoclax Therapy for 18-Year-Old Male with Ataxia Telangiectasia and Early T-Cell Precursor Acute Lymphoblastic Leukemia
Authors: Shaikha Alqahtani, Ramya Ramakrishnan, Cesar Nunez, David McCall, Miriam B. Garcia, Branko Cuglievan, Amber Gibson
Journal: Blood (2023)
Promising Safety and Efficacy of Trovocabtagene Autoleucel (C-CAR088) Followed ASCT in Ultra High-Risk Multiple Myeloma (UHR-MM) Patients Who Failed or Had Suboptimal Response to Standard First Line Triplet Based Therapy
Authors: Yan Xu, Wensi Li, Gang An, Weiwei Sui, Shuhui Deng, Tingyu Wang, Shuhua Yi, Wenyang Huang, Wei Liu, Qi Wang, Rui Lv, Wenjie Xiong, Chenxing Du, Judy Zhu, Jiaqi Huang, Chengxiao Zheng, Liping Lan, Kevin Zhu, Lugui Qiu, Dehui Zou
Journal: Blood (2023)
Identification of <i>MYC</i>-Driven High-Grade B-Cell Lymphoma Using Deep Learning-Based Whole Slide Image Analysis
Authors: Anil Yüce, Christian Doerig, Jacob Gildenblat, Samaneh Abbasi-Sureshjani, Agata Mosinska, Heather Wright, Wilfred Leung, Yanwen Jiang, Patrick Kimes, Camille Laurent, Konstanty Korski, Markus D Herrmann
Journal: Blood (2023)